Post by MikeTesteron Jan 24, 2025 11:05am
159 Views
Post# 36418969
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS): A Pioneering
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS): A Pioneering Looks like SELLAS is cooking up something big in the cancer treatment space. 50% response rate in AML with SLS009 is no joke. Especially that 100% response in ASXL1 mutated patients - that's a game changer. Might start building a small position here. Phase 3 REGAL study for GPS looks promising too, with IDMC recommending trial continuation. Cash position of $21M gives them runway to keep pushing forward. Regulatory designations like Orphan Drug and Rare Pediatric Disease status could be huge value catalysts. BeyondSPX always delivers high quality in-depth analysis on just about every US stock out there, even microcaps, for free. Watching this one closely. https://beyondspx.com/article/sellas-life-sciences-group-inc-nasdaqsls-a-pioneering-biopharmaceutical-company-poised-to-revolutionize-cancer-treatment